ACTIVE_NOT_RECRUITING

Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the study is to assess the feasibility and participant satisfaction with the Support through Remote Observation and Nutrition Guidance (STRONG) program. The program provides enhanced dietician access and nutrition support for participants living with pancreatic cancer who are receiving chemotherapy.

Official Title

Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients

Quick Facts

Study Start:2022-12-21

Study Completion:2026-05

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:ACTIVE_NOT_RECRUITING

Study ID

NCT05675059

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* 18 years of age or older * Diagnosed metastatic or newly recurrent pancreatic cancer or locally advanced pancreatic cancer * Receiving chemotherapy under the guidance of Moffitt * Able to speak and read English * Able to provide informed consent	* Documented or observable psychiatric or neurological disorder that would interfere with study participation (e.g., psychosis, active substance abuse). * Undergoing concurrent treatment for a second primary GI cancer * ECOG status of 2 or greater * Use of parenteral or enteral nutrition * Presence of malignant ascites

Contacts and Locations

Principal Investigator

Amir Alishahi Tabriz, MD, PhD, MPH

PRINCIPAL_INVESTIGATOR

Moffitt Cancer Center

Pamela Hodul, MD

PRINCIPAL_INVESTIGATOR

Moffitt Cancer Center

Study Locations (Sites)

Moffitt Cancer Center

Tampa, Florida, 33612

United States

Collaborators and Investigators

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Amir Alishahi Tabriz, MD, PhD, MPH, PRINCIPAL_INVESTIGATOR, Moffitt Cancer Center
Pamela Hodul, MD, PRINCIPAL_INVESTIGATOR, Moffitt Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-12-21

Study Completion Date2026-05

Study Record Updates

Study Start Date2022-12-21

Study Completion Date2026-05

Terms related to this study

Additional Relevant MeSH Terms

Pancreatic Cancer